PanGen Biotech (Korea) Probability of Future Stock Price Finishing Over 3,968
| 222110 Stock | KRW 5,720 260.00 4.76% |
PanGen |
PanGen Biotech Target Price Odds to finish over 3,968
The tendency of PanGen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5,720 | 90 days | 5,720 | about 18.17 |
Based on a normal probability distribution, the odds of PanGen Biotech to move above the current price in 90 days from now is about 18.17 (This PanGen Biotech probability density function shows the probability of PanGen Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon PanGen Biotech has a beta of -0.49. This suggests as returns on the benchmark increase, returns on holding PanGen Biotech are expected to decrease at a much lower rate. During a bear market, however, PanGen Biotech is likely to outperform the market. Additionally PanGen Biotech has an alpha of 0.6374, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). PanGen Biotech Price Density |
| Price |
Predictive Modules for PanGen Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PanGen Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.PanGen Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PanGen Biotech is not an exception. The market had few large corrections towards the PanGen Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PanGen Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PanGen Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | -0.49 | |
σ | Overall volatility | 903.93 | |
Ir | Information ratio | 0.08 |
PanGen Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PanGen Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PanGen Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PanGen Biotech is way too risky over 90 days horizon | |
| PanGen Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B. | |
| PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations. | |
| Roughly 33.0% of the company shares are owned by insiders or employees |
PanGen Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PanGen Stock often depends not only on the future outlook of the current and potential PanGen Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PanGen Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.7 M | |
| Cash And Short Term Investments | 23.9 B | |
| Shares Float | 5.6 M |
PanGen Biotech Technical Analysis
PanGen Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. PanGen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PanGen Biotech. In general, you should focus on analyzing PanGen Stock price patterns and their correlations with different microeconomic environments and drivers.
PanGen Biotech Predictive Forecast Models
PanGen Biotech's time-series forecasting models is one of many PanGen Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PanGen Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about PanGen Biotech
Checking the ongoing alerts about PanGen Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PanGen Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PanGen Biotech is way too risky over 90 days horizon | |
| PanGen Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B. | |
| PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations. | |
| Roughly 33.0% of the company shares are owned by insiders or employees |
Other Information on Investing in PanGen Stock
PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.